Thymosin Alpha-1
Synthetic 28-amino-acid peptide matching the sequence of thymosin alpha-1. Referenced in immune-modulation and T-cell differentiation research.
What the literature says.
Mechanism of action
Referenced mechanisms include TLR-2 and TLR-9 pathway modulation in dendritic cells, effects on regulatory and cytotoxic T-cell populations, and shifts in cytokine expression profiles.
Preclinical summary
Thymosin alpha-1 is a 28-residue peptide first isolated from thymic extracts. Research literature covers T-cell differentiation, TLR signaling, and antiviral-model endpoints.
Safety
Research material only. Not a drug, supplement, or food product. No human or animal administration is supported or implied. Handling should follow the purchaser's institutional biosafety and chemical hygiene protocols.
Shipping & storage
Ships overnight in insulated packaging with ice packs when lab conditions require. Store lyophilized powder at 2–8°C. After reconstitution, store at 2–8°C and use within standard stability windows documented on the lot-specific Certificate of Analysis.
The compound, in numbers.
Research use only.
These products are intended for laboratory research purposes only and are not for human or animal consumption.
The statements on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
